Duke of York opens Stiefel's Eurasia headquarters in UK

Published: 1-Dec-2009
Recruitment

HRH The Duke of York has opened Stiefel Laboratories' Eurasia headquarters in Maidenhead, Berkshire.

The 4,645m2 office, which employs 180 people, consolidates Stiefel Laboratories' r&d and commercial entities in the UK and helps the company develop innovative skincare treatments. Stiefel already manufactures Oilatum for the treatment of eczema and claims to be the first to introduce benzoyl peroxide to treat acne.

The Duke of York toured the new offices with Gabriel McGlynn, Stiefel's senior vice president, Eurasia, and visited a photographic exhibition devoted to the company's 160-year history.

McGlynn said: "The move to Maidenhead is an important step for Stiefel Laboratories in the UK as it enables us to work more efficiently as a team rather than being based across two sites and ensures our focus will be on creating groundbreaking skincare solutions."

The Eurasia hq is carbon neutral and in recognition of this, the company was recently awarded a BREEAM (Building Research Establishment Environmental Assessment Award) certificate of "Very Good".

See more

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

Read more
During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel

Trending Articles

  1. hard to swallow...
  2. People on the Move US biotechnology company <i>La Jolla Pharmaceutical</i> has promoted <b>Gail Sloan</b> to vice president of finance, controller and secretary. Sloan has previously worked with Affymax Research Institute and Ernst & Young.
  3. Bioprogress appoint new position and restructure board <p>BioProgress, the speciality pharmaceutical and healthcare company, has announced the creation of a new executive operational board, and the appointment of Keith Hemming, as head of operations in a new position within the management team of the company.</p>
  4. Drug formulation and delivery expert Dr Joseph Reo appointed as Catalent’s Director of Global Scientific Affairs Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced the appointment of Dr Joseph (Joe) Reo to the role of Director of Global Scientific Affairs
  5. People on the move

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Recruitment

Vetter Pharma invests $4.1m in Ravensburg training facility

The centre opened on September 14, with a small celebration held for management, training management and trainees.
Recruitment

Does pharma have a problem with inclusivity and innovation?

As we’ve seen only too clearly in recent weeks, the pharmaceutical industry is of paramount importance to the global economy and society. The collaboration regarding the COVID-19 pandemic is an example of the sector at its best, reports Stephen Frost, Founder, Frost Included
Recruitment

Cell Mogrify undergoes period of change

A cash injection and change in leadership gives momentum to the cell therapy company for direct cellular conversion platform
Recruitment

Novartis scoops Top Employer award

Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute
Recruitment

Retention, not just recruitment

Six ways to protect your company from the skills crisis
Recruitment

Particle Testing Authority (PTA) boosts company's thermal analysis capabilities

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, now has expanded thermal analysis capabilities with addition of Bryan Shaw to its team
Subscribe now